Clinical trial
Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects With Stress Urinary Incontinence
NCT02210273 is registered in ClinicalTrials.gov with Solace Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Solace Bladder Control System in the Treatment of Female Subjects With Stress Urinary Incontinence
- Lead sponsor
- Solace Therapeutics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 11, 2014
- Completion date
- March 30, 2019
- Enrollment
- 221 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
stress urinary incontinence